7/29/2019 Clinical Trial Protocol

1/21

N`mcmnf` Urmf` Zratana`

7/29/2019 Clinical Trial Protocol

2/21

Ua fcswor f n`mcmnf` prai`odUa gfmc cow kcaw`oego fiaut f cow ar ostfi`msh

troftdoct

Ua suppart f n`fmd-lar gfmcmcg gavorcdoct rogu`ftary fppravf`

-lar dfrkotmcg f erug, eovmno, ar tonhcmquo

Why ea f n`mcmnf` trmf`1

7/29/2019 Clinical Trial Protocol

3/21

F n`mcmnf` trmf` pratana` nactfmcs f stuey p`fc ac whmnh tho n`mcmnf`

ifsoe

MNH gumeo`mcos stfto2

F eanudoct thft eosnrmios tho aibontmvo(s), eosmgc, dothaea`agy

nacsmeorftmacs fce argfcmzftmac al f trmf`

Uho pratana` usuf``y f`sa gmvos tho ifnkgrauce fce rofsac tho trm

naceuntoe, iut thoso nau`e io pravmeoe mc athor eanudocts rolo

tho pratana` (sunh fs fc mcvostmgftars iranhuro).

Whft ms f pratana`1

7/29/2019 Clinical Trial Protocol

4/21

Mcstrunts stuey tofd ac oxfnt`y whft ta ea

Oxp`fmcs tho stuey ta tho autsmeo war`e

Zravmeos f rovmowfi`o eanudoct lar

conossfry fppravf`s

whft ms tho purpaso1

7/29/2019 Clinical Trial Protocol

5/21

Othmns

^nmoctmlmn vf`memty fce mctogrmty

Doemnf` ro`ovfcno

Yogu`ftary fce doemna `ogf` mssuos

Nasts

Gumemcg prmcnmp`os

7/29/2019 Clinical Trial Protocol

6/21

aMctraeuntmac fce rftmacf`o

a

^tuey aibontmvos2 prmdfry fce sonacefryaAvorf`` stuey eosmgc

a^tuey l`aw shoot

aOcra``doct nrmtormf

a^ponmlmn stuey pranoeuros

aYfceadmzftmac

aMctorvoctmacaAutnado dofsurodocts

aZratana` eovmftmacs

aEftf fcf`ysms fce stftmstmns

aOthmnf` nacsmeorftmacs (Eon`frftmac al Ho`smckm)

Fcftady al f typmnf` stuey pratana

7/29/2019 Clinical Trial Protocol

7/21

O`odoct Zurpaso6. Yosofrnh quostmacs Whft quostmacs wm`` tho stuey feeross19. mgcmlmnfcno (ifnkgrauce) Why fro thoso quostmacs mdpartfct1>. Eosmgc

Umdo lrfdoOpmeodma`agmn fpprafnh

Haw ms tho stuey strunturoe1

5. ^uibonts

^o`ontmac nrmtormf^fdp`mcg eosmgc

Wha fro tho suibonts fce haw wm`` thoy i

?. \frmfi`os

Zroemntar vfrmfi`osNaclaucemcg vfrmfi`osAutnado vfrmfi`os

Whft dofsurodocts wm`` io dfeo1

7/29/2019 Clinical Trial Protocol

8/21

Dfbar hofemcgs mc f pratanaUmt`o

Mcvostmgftars, mcstmtutmacf` fllm`mftmacs, & quf`mlmnftmacs

^uddfry/Fistrfnt

6. Mctraeuntmac

@mtorfturo rovmow; Datmvftmac lar tho stuey (prai`od); Zurpaso; ponmlmn aibontmvos; Mdp`odo

9. Dothaes

Eolmcmtmac al tords; tuey eosmgc; tuey papu`ftmac fce sfdp`mcg; Dofsurodocts; Zm`at stue

>. @agmstmns fce tmdo snhoeu`o

Yospacsmim`mtmos al mcvostmgftars fce al stfll; Umdo snhoeu`o

5. Eftf dfcfgodoct fce fcf`ysms

?. Yosaurnos

Fvfm`fi`o rosaurnos; Iuegot fce iuegot datmvftmac

7/29/2019 Clinical Trial Protocol

9/21

Nadpacocts al f rosofrnh prapaF. Umt`o pfgoI. Ufi`o al nactocts

N. FistrfntE. Zrabont Eosnrmptmac

6. Mctraeuntmac9. Zrai`od stftodoct fce smgcmlmnfcno>. Gaf`s fce aibontmvos5. Dothaes fce pranoeuros

?. Ovf`uftmac

7/29/2019 Clinical Trial Protocol

10/21

Dfmc pratana` o`odocts

Uho fiavo pratana` aut`mcos hfvo thoso fs dfmc o`od

Zapu`ftmac

Vuostmac

Yo`ovfcno

^tuey eosmgc fce vfrmfi`os Umdolrfdo

Ua uceorstfce thoso, wo cooe ta rovmsmt sadoopmeodma`agy

7/29/2019 Clinical Trial Protocol

11/21

Umt`o pfgo2

Zratana` tmt`o, pratana` meoctmlymcg cudior fce efto. Fcy fdoced

shau`e f`sa iofr tho fdocedoct cudior(s) fce efto(s).

Cfdo fce feeross al tho spacsar fce dacmtar(ml athor thfc tho sp

Naclmeoctmf`mty stftodoct

Ufi`o al nactocts

Ofsy rolorocno taa`

Gocorf` mclardftmac

7/29/2019 Clinical Trial Protocol

12/21

Uypmnf` Mcn`usmac nrmtormf

^uibont dust hfvo emsofso al mctorost

^uibont dust hfvo f nortfmc fdauct al emsofso

^uibont dust uceorstfce stuey fce fgroo ta pfrtmnmpf

Athor

Uypmnf` oxn`usmac nrmtormf

^uibont dust cat io ac fc fntmvo troftdoct

^uibont dust cat io f``orgmn ta mctorvoctmac

Zrogcfcny, irofstlooemcg nhm`e

Athor

7/29/2019 Clinical Trial Protocol

13/21

^uibont mcn`usmac nrmtormf.

^uibont oxn`usmac nrmtormf.

^uibont wmtherfwf` nrmtormf (m.o., tordmcftmcg mcvostmgftmacf` praeunt troft

troftdoct) fce pranoeuros sponmlymcg2

(f) Whoc fce haw ta wmtherfw suibonts lrad tho trmf`/ mcvostmgftmacf` prae

troftdoct.

(i) Uho typo fce tmdmcg al tho eftf ta io na``ontoe lar wmtherfwc suibonts.

(n) Whothor fce haw suibonts fro ta io rop`fnoe.

(e) Uho la``aw-up lar suibonts wmtherfwc lrad mcvostmgftmacf` praeunt trof

troftdoct.

7/29/2019 Clinical Trial Protocol

14/21

7/29/2019 Clinical Trial Protocol

15/21

7.Fssossdoct al Ollmnfny

^ponmlmnftmac al tho ollmnfny pfrfdotors.

Dothaes fce tmdmcg lar fssossmcg, ronaremcg, fce fcf`yzmcg ollmnfny pfr

8. Fssossdoct al ^floty

^ponmlmnftmac al sfloty pfrfdotors.

Uho dothaes fce tmdmcg lar fssossmcg, ronaremcg, fce fcf`yzmcg sfloty

pfrfdotors.Zranoeuros lar o`mnmtmcg roparts al fce lar ronaremcg fce ropartmcg fevo

fce mctornurroct m``cossos.

Uho typo fce eurftmac al tho la``awup al suibonts fltor fevorso ovoc

7/29/2019 Clinical Trial Protocol

16/21

=. ^tftmstmns

_soe ta eotordmco tho smgcmlmnfcno al tho stuey eftf ifsoe ac `fws al prF`sa usoe ta eotordmco tho pawor al f stuey (m.o. cudior al pftmocts cooe

ronrumt)

F eosnrmptmac al tho stftmstmnf` dothaes ta io odp`ayoe, Mcn`uemcg tmdmcg

p`fccoe mctormd fcf`ysms.

Uho cudior al suibonts p`fccoe ta io ocra``oe. Mc du`tmnoctor trmf`s, tho

ocra``oe suibonts prabontoe lar ofnh trmf` smto shau`e io sponmlmoe.Yofsac lar nhamno al sfdp`o smzo, mcn`uemcg rol`ontmacs ac tho pawor al th

n`mcmnf` bustmlmnftmac.

Nrmtormf lar tho tordmcftmac al tho trmf`.

Zranoeuro lar fnnauctmcg lar dmssmcg, ucusoe, fce spurmaus eftf.

7/29/2019 Clinical Trial Protocol

17/21

Zranoeuros lar ropartmcg fcy eovmftmac(s) lrad tho armgmcf` stftmstmnf` p`f

eovmftmac(s) lrad tho armgmcf` stftmstmnf` p`fc shau`e io eosnrmioe fce bust

pratana` fce/ar mc tho lmcf` ropart, fs fppraprmfto).

Uho so`ontmac al suibonts ta io mcn`ueoe mc tho fcf`ysos (o.g.. f`` rfcead

f`` easoe suibonts, f`` o`mgmi`o suibonts, ovf`uftofi`o suibonts).

7/29/2019 Clinical Trial Protocol

18/21

6:. Emront Fnnoss ta ^aurno Eftf Eanudocts

Uho spacsar shau`e ocsuro thft mt ms sponmlmoe mc tho pratana` ar athor wr

fgroodoct thft tho mcvostmgftar(s)/mcstmtutmac(s) wm`` pordmt trmf`- ro`ftoe

fuemts, MYI/MON rovmow, fce rogu`ftary mcspontmac(s) iy pravmemcg emront f

saurno eftf/eanudocts.

66. Vuf`mty Nactra` fce Vuf`mty Fssurfcno

7/29/2019 Clinical Trial Protocol

19/21

69. Othmns

Eosnrmptmac al othmnf` nacsmeorftmacs ro`ftmcg ta tho trmf`.

6>. Eftf Hfce`mcg fce Yonarekoopmcg

65. Lmcfcnmcg fce Mcsurfcno

Lmcfcnmcg fce mcsurfcno fro feerossoe mc f sopfrfto fgroodoc

7/29/2019 Clinical Trial Protocol

20/21

6?. Zui`mnftmac Za`mnyZui`mnftmac pa`mny, ml cat feerossoe mc f sopfrfto fgroodoct.

6

7/29/2019 Clinical Trial Protocol

21/21